Literature DB >> 21912193

Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a surveillance, epidemiology and end results program-based analysis.

Nabil F Saba1, Michael Goodman, Kevin Ward, Chris Flowers, Suresh Ramalingam, Taofeek Owonikoko, Amy Chen, William Grist, Trad Wadsworth, Jonathan J Beitler, Fadlo R Khuri, Dong M Shin.   

Abstract

BACKGROUND: Squamous cell carcinomas (SCC) of the oral tongue (OT) and of the base of the tongue and tonsils (BTT) differ with respect to etiology, treatment and prognosis. Human papillomavirus has been linked to the increased incidence of BTT, yet, the trends in incidence of BTT and OT tumors among gender and ethnic origin groups have not been well examined. We sought to examine the trend in gender-, ethnic origin- and age-specific incidence of these tumors over time.
METHODS: Data were obtained from the Surveillance, Epidemiology and End Results Program of the US National Cancer Institute. We examined temporal trends in sex- and ethnic origin-specific incidence of SCC by calculating the annual percent changes followed by joinpoint analyses evaluating changes in trend.
RESULTS: While BTT increased in age-adjusted rates among white males with a more pronounced increase observed in the mid-1990s, white females experienced a significant increase in incidence of OT tumors. Patients with advanced OT carcinoma had a significantly lower survival compared to those with advanced BTT disease; however, patients with early-stage OT tumors had a better survival compared to patients with BTT.
CONCLUSIONS: While the increase in incidence of BTT tumors in white men is likely human papillomavirus driven, more studies are needed to elucidate the increasing incidence of OT tumors in white women. The differences in outcomes across ethnic origin groups are also described and discussed.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21912193      PMCID: PMC3186716          DOI: 10.1159/000330807

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  15 in total

1.  Permutation tests for joinpoint regression with applications to cancer rates.

Authors:  H J Kim; M P Fay; E J Feuer; D N Midthune
Journal:  Stat Med       Date:  2000-02-15       Impact factor: 2.373

Review 2.  The surveillance, epidemiology, and end results program: a national resource.

Authors:  B F Hankey; L A Ries; B K Edwards
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-12       Impact factor: 4.254

3.  Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data.

Authors:  Natia Esiashvili; Michael Goodman; Robert B Marcus
Journal:  J Pediatr Hematol Oncol       Date:  2008-06       Impact factor: 1.289

Review 4.  Global epidemiology of oral and oropharyngeal cancer.

Authors:  Saman Warnakulasuriya
Journal:  Oral Oncol       Date:  2008-09-18       Impact factor: 5.337

Review 5.  Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity.

Authors:  Maura L Gillison
Journal:  Semin Oncol       Date:  2004-12       Impact factor: 4.929

6.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

7.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

Authors:  M L Gillison; W M Koch; R B Capone; M Spafford; W H Westra; L Wu; M L Zahurak; R W Daniel; M Viglione; D E Symer; K V Shah; D Sidransky
Journal:  J Natl Cancer Inst       Date:  2000-05-03       Impact factor: 13.506

8.  Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer.

Authors:  Michelle S Ludwig; Michael Goodman; Daniel L Miller; Peter A S Johnstone
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

9.  Case-control study of human papillomavirus and oropharyngeal cancer.

Authors:  Gypsyamber D'Souza; Aimee R Kreimer; Raphael Viscidi; Michael Pawlita; Carole Fakhry; Wayne M Koch; William H Westra; Maura L Gillison
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

10.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Authors:  Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

View more
  35 in total

1.  Proapoptotic, anti-cell proliferative, anti-inflammatory and anti-angiogenic potential of carnosic acid during 7,12 dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis.

Authors:  Duraisamy Rajasekaran; Shanmugam Manoharan; Simon Silvan; Krishnamoorthy Vasudevan; Nagarethinam Baskaran; Duraisamy Palanimuthu
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-10-01

2.  Significant association of the cytokine variants with head and neck cancer risk: evidence from meta-analysis.

Authors:  Ting-Ting Xiao; Xian Li; Ying Xu; Yong Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-11-28       Impact factor: 2.503

3.  Head and neck PET/CT therapy response interpretation criteria (Hopkins criteria) - external validation study.

Authors:  Ayse Tuba Kendi; David Brandon; Jeffrey Switchenko; Jeffery Trad Wadsworth; Mark W El-Deiry; Nabil F Saba; David M Schuster; Rathan M Subramaniam
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-09-01

4.  Impact of obesity on the survival of patients with early-stage squamous cell carcinoma of the oral tongue.

Authors:  Neil M Iyengar; Amit Kochhar; Patrick G Morris; Luc G Morris; Xi K Zhou; Ronald A Ghossein; Alejandro Pino; Matthew G Fury; David G Pfister; Snehal G Patel; Jay O Boyle; Clifford A Hudis; Andrew J Dannenberg
Journal:  Cancer       Date:  2014-01-21       Impact factor: 6.860

5.  Mutation and Transcriptional Profiling of Formalin-Fixed Paraffin Embedded Specimens as Companion Methods to Immunohistochemistry for Determining Therapeutic Targets in Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Pilot of Proof of Principle.

Authors:  Nabil F Saba; Malania Wilson; Gregory Doho; Juliana DaSilva; R Benjamin Isett; Scott Newman; Zhuo Georgia Chen; Kelly Magliocca; Michael R Rossi
Journal:  Head Neck Pathol       Date:  2014-09-19

6.  Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.

Authors:  Ding Ding; William Stokes; Megan Eguchi; Mohammad Hararah; Whitney Sumner; Arya Amini; Julie Goddard; Hilary Somerset; Cathy Bradley; Jessica McDermott; David Raben; Sana D Karam
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-01-01       Impact factor: 6.223

Review 7.  Next-generation prognostic assessment for diffuse large B-cell lymphoma.

Authors:  Ashley D Staton; Jean L Koff; Qiushi Chen; Turgay Ayer; Christopher R Flowers
Journal:  Future Oncol       Date:  2015-08-20       Impact factor: 3.404

8.  White adipose tissue inflammation and cancer-specific survival in patients with squamous cell carcinoma of the oral tongue.

Authors:  Neil M Iyengar; Ronald A Ghossein; Luc G Morris; Xi K Zhou; Amit Kochhar; Patrick G Morris; David G Pfister; Snehal G Patel; Jay O Boyle; Clifford A Hudis; Andrew J Dannenberg
Journal:  Cancer       Date:  2016-08-10       Impact factor: 6.860

9.  Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma.

Authors:  Qiushi Chen; Turgay Ayer; Loretta J Nastoupil; Jean L Koff; Ashley D Staton; Jagpreet Chhatwal; Christopher R Flowers
Journal:  Leuk Lymphoma       Date:  2015-12-15

10.  Racial differences in head and neck squamous cell carcinomas among non-Hispanic black and white males identified through the National Cancer Database (1998-2012).

Authors:  Caryn E Peterson; Shaveta Khosla; Lucy F Chen; Charlotte E Joslin; Faith G Davis; Marian L Fitzgibbon; Sally Freels; Kent Hoskins
Journal:  J Cancer Res Clin Oncol       Date:  2016-06-01       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.